New York, New York, United StatesFounded 202031+ employeesPrivate
Acquired· last: series unknown (Nov 2021)· 1 rounds
Backed by(2 investors)
Biospring Partners · Lead+1 more
Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and deliver the promise of these therapies to impact patients’ lives. Bringing novel treatments to the patients who need them most — in an economically viable way — is too often crippled by persistent bottlenecks, constraints and inefficiencies in the development, manufacturing and delivery of those innovations
